DIFFICULTIES OF MINIMAL RESIDUAL DISEASE MONITORING BY NESTED PCR IN TEL-AML1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN

被引：0
|
作者：
Colita, A. [1 ]
Radu, L. E. [1 ]
Dumitru, J. [2 ]
Dragomir, M. [2 ]
Jardan, C. [3 ]
Gheorghe, A. [4 ]
Coriu, D. [1 ]
Arion, C. [1 ]
机构：
[1] Fundeni Clin Inst, Bucharest, Romania
[2] Fundeni Clin Inst, Mol Biol Lab, Bucharest, Romania
[3] Fundeni Clin Inst, Genet Lab, Bucharest, Romania
[4] Fundeni Clin Inst, Immunophenotyping Lab, Bucharest, Romania
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1406
引用
收藏
页码：549 / 549
页数：1
相关论文
共 50 条
  • [21] Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study
    Mosad, Eman
    Hamed, Hosny B.
    Bakry, Rania M.
    Ezz-Eldin, Azza M.
    Khalifa, Nesrine M.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2008, 1 (1)
  • [22] MONITORING OF MINIMAL RESIDUAL DISEASE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    LINDERKAMP, C
    BEYERMANN, B
    BAUMGARTEN, E
    HANEL, C
    SEEGER, K
    SCHMID, H
    ZINGSEM, J
    HENZE, G
    BLOOD, 1993, 82 (10) : A543 - A543
  • [23] An update on PCR use for minimal residual disease monitoring in acute lymphoblastic leukemia
    Nunes, Vittorio
    Cazzaniga, Gianni
    Biondi, A.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (11) : 953 - 963
  • [24] TEL-AML1 fusion in acute lymphoblastic leukemia with L3 morphology
    Abdelhaleem, Mohamed
    Shago, Mary
    Abla, Oussama
    PEDIATRIC BLOOD & CANCER, 2007, 49 (02) : 217 - 217
  • [25] TEL-AML1 fusion in acute lymphoblastic leukaemia of adults
    Aguiar, RCT
    Sohal, J
    vanRhee, F
    Carapeti, M
    Franklin, IM
    Goldstone, AH
    Goldman, JM
    Cross, NCP
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 95 (04) : 673 - 677
  • [26] Treatment with VDLP induction chemotherapy in acute lymphoblastic leukemia with TEL-AML1 and TEL-ABL rearrangements
    Mao Shuting
    Liu Yufeng
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2017, 12 : S33 - S33
  • [27] Clonotypic analysis of acute lymphoblastic leukemia with a double TEL-AML1 fusion at onset and relapse
    Inukai, T
    Yokota, S
    Okamoto, T
    Nemoto, A
    Akahane, K
    Takahashi, K
    Sato, H
    Goi, K
    Nakazawa, S
    Sugita, K
    LEUKEMIA, 2006, 20 (02) : 363 - 365
  • [28] Persistence of TEL-AML1 transcript in acute lymphoblastic leukemia in long-term remission
    Endo, C
    Oda, M
    Nishiuchi, R
    Seino, Y
    PEDIATRICS INTERNATIONAL, 2003, 45 (03) : 275 - 280
  • [29] Treatment with VDLP induction chemotherapy in acute lymphoblastic leukemia with TEL-AML1 and TEL-ABL rearrangements
    Mao Shuting
    Liu Yufeng
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2017, 12 : S33 - S33
  • [30] TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia
    Sabaawy, Hatem E.
    Azuma, Mizuki
    Embree, Lisa J.
    Tsai, Huai-Jen
    Starost, Matthew F.
    Hickstein, Dennis D.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (41) : 15166 - 15171
12345